142 related articles for article (PubMed ID: 1552197)
1. Nephrotoxicity and ototoxicity of aztreonam versus aminoglycoside therapy in seriously ill nonneutropenic patients.
Moore RD; Lerner SA; Levine DP
J Infect Dis; 1992 Apr; 165(4):683-8. PubMed ID: 1552197
[TBL] [Abstract][Full Text] [Related]
2. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
[TBL] [Abstract][Full Text] [Related]
3. Comparative clinical evaluation of aztreonam versus aminoglycosides in gram-negative septicaemia.
Gudiol F; Pallarés R; Ariza X; Fernández-Viladrich P; Rufi G; Liñares J
J Antimicrob Chemother; 1986 May; 17(5):661-71. PubMed ID: 3722035
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli.
DeMaria A; Treadwell TL; Saunders CA; Porat R; McCabe WR
Antimicrob Agents Chemother; 1989 Aug; 33(8):1137-43. PubMed ID: 2679368
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.
Rybak MJ; Abate BJ; Kang SL; Ruffing MJ; Lerner SA; Drusano GL
Antimicrob Agents Chemother; 1999 Jul; 43(7):1549-55. PubMed ID: 10390201
[TBL] [Abstract][Full Text] [Related]
6. Aminoglycoside ototoxicity.
Matz GJ
Am J Otolaryngol; 1986; 7(2):117-9. PubMed ID: 3485932
[TBL] [Abstract][Full Text] [Related]
7. Aztreonam.
Cunha BA
Urology; 1993 Mar; 41(3):249-58. PubMed ID: 8442309
[TBL] [Abstract][Full Text] [Related]
8. Aminoglycoside nephrotoxicity in obstructive jaundice.
Desai TK; Tsang TK
Am J Med; 1988 Jul; 85(1):47-50. PubMed ID: 3389381
[TBL] [Abstract][Full Text] [Related]
9. Aminoglycoside therapy. Improving patient response and safety.
Ackerman BH; Bailie GR; Zaske DE
Postgrad Med; 1984 Feb; 75(2):177-86. PubMed ID: 6607465
[TBL] [Abstract][Full Text] [Related]
10. Aminoglycoside nephrotoxicity: do time and frequency of administration matter?
Beauchamp D; Labrecque G
Curr Opin Crit Care; 2001 Dec; 7(6):401-8. PubMed ID: 11805542
[TBL] [Abstract][Full Text] [Related]
11. [Ototoxicity of aminoglycoside antibiotics].
Reiss M; Reiss G
Praxis (Bern 1994); 2003 Jan; 92(4):127-33. PubMed ID: 12632843
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group.
Marco V; Gobernado M; Santos M; Rabinad E
Chemotherapy; 1989; 35 Suppl 1():81-8. PubMed ID: 2659295
[TBL] [Abstract][Full Text] [Related]
13. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.
Pauly DJ; Musa DM; Lestico MR; Lindstrom MJ; Hetsko CM
Pharmacotherapy; 1990; 10(6):378-82. PubMed ID: 2287556
[TBL] [Abstract][Full Text] [Related]
14. Role of aztreonam in lower respiratory tract infections.
Cook JL
Urology; 1988 Jun; 31(6 Suppl):33-6. PubMed ID: 3287748
[TBL] [Abstract][Full Text] [Related]
15. Nephrotoxicity of vancomycin, alone and with an aminoglycoside.
Rybak MJ; Albrecht LM; Boike SC; Chandrasekar PH
J Antimicrob Chemother; 1990 Apr; 25(4):679-87. PubMed ID: 2351627
[TBL] [Abstract][Full Text] [Related]
16. Aztreonam in the treatment of serious gram-negative infections in the elderly.
Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
[TBL] [Abstract][Full Text] [Related]
17. Aztreonam.
Johnson DH; Cunha BA
Med Clin North Am; 1995 Jul; 79(4):733-43. PubMed ID: 7791420
[TBL] [Abstract][Full Text] [Related]
18. Effect of furosemide on aminoglycoside-induced nephrotoxicity and auditory toxicity in humans.
Smith CR; Lietman PS
Antimicrob Agents Chemother; 1983 Jan; 23(1):133-7. PubMed ID: 6830203
[TBL] [Abstract][Full Text] [Related]
19. Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.
Cimino MA; Rotstein C; Slaughter RL; Emrich LJ
Am J Med; 1987 Dec; 83(6):1091-7. PubMed ID: 3503577
[TBL] [Abstract][Full Text] [Related]
20. [Aztreonam as monotherapy in urinary tract infections with a systemic repercussion in patients with a relative contraindication for the use of aminoglycosides].
Pedrajas JM; Pieltain R; Mesa N; Ramón P; García C; Pontes JC; Fernández-Cruz A
Rev Clin Esp; 1993 Apr; 192(6):256-9. PubMed ID: 8497718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
